SCHEMBL5451441

SCHEMBL5451441

Cc1c(-c2ccccc2)c(N2CCCC2N(C)C)n2cc(C(C)C)nc2c1C#N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.36
CCND3 P30281 1/20 0.36
ALDH1A1 P00352 7/20 0.34
KDM4E B2RXH2 7/20 0.34
HPGD P15428 6/20 0.34
HSD17B10 Q99714 3/20 0.34
MAPT P10636 3/20 0.34
MAPK1 P28482 1/20 0.34
ADORA3 P0DMS8 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
GRM5 P41594 2/20 0.32
ADORA2A P29274 3/20 0.32
ADRA2A P08913 2/20 0.32
HTT P42858 2/20 0.32
NPC1 O15118 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5446969 0.89 CDK4 (0.39) CDK4CCND3ALDH1A1KDM4EHPGD
SCHEMBL5444083 0.82 GRM5 (0.34) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL5451444 0.82 CDK4 (0.40) CDK4CCND3ALDH1A1KDM4EHPGD
SCHEMBL5440184 0.81 PTPN11 (0.37) ALDH1A1SMN1; SMN2NPC1CYP1A2CYP3A4
SCHEMBL5458301 0.80 GRM5 (0.36) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL5442795 0.79 GRM5 (0.35) CDK4ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5444472 0.78 ALDH1A1 (0.39) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL5442736 0.78 PDE4D (0.37) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL5446968 0.77 LMNA (0.35) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL5447395 0.77 LMNA (0.35) ALDH1A1KDM4EHPGDHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070191395-A1 Heterocyclic compounds having antifungal activity DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-08-16 US disclosed
EP-1717238-A1 FUNGICIDAL HETEROCYCLIC COMPOUNDS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191395-A1 Heterocyclic compounds having antifungal activity ERG28, MANBA, MAN2B1 CDK4 2554/4885CCND3 3674/4885ALDH1A1 1357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.